News and blogs
20 results found.
“Science is sexy"
Liz Thomas was diagnosed with Chronic Myeloid Leukemia (CML) in December 2018. Today, on World CML Day, she's sharing her story with us.
The Government should give financial support and clear guidance to people with blood cancer
His Royal Highness The Duke of Kent marks Blood Cancer Awareness Month
His Royal Highness the Duke of Kent has been our Patron since 1972. He has written the following article to mark our 60th anniversary, to reflect on the challenges of the coronavirus for people with blood cancer, and to look at the wider impact on all charities.
My care team gave me my life back, how can "thank you" ever be enough?
Steve Gunby is taking on the 2020 Virtual London to Paris cycle after being diagnosed with Myeloma in 2019. He'd never taken on 300 miles before, but he grew into the challenge...
Announcement on sponsorship of Blenheim Triathlon
Five years on, our family is living free from the restraints of blood cancer
Lisa reflects on the impact that leukaemia has had on her son Hugo, and their whole family. From the path to diagnosis and the grueling side effects of treatment, to Hugo finally finishing treatment. Now, they look forward to embracing every moment of life.
Turning leukaemia on its head
Despite the harsh side effects of Yvonne's treatment for leukaemia, she was determined to keep as active as she could. By adapting her approach to fitness, Yvonne was able to come back even stronger.
We've saved so many lives in the last 60 years, because of Susan.
It's been 60 years since my parents started this charity. We've grown to become thousands of families, and achieved so much along the way. But it all started with my little sister, Susan.
Does having blood cancer put you at greater risk from the coronavirus?
This week the Lancet Oncology published the largest study into coronavirus and cancer. It looked at whether some types of cancer put people at higher risk from the coronavirus than others.
An announcement about Blood Cancer UK
The last few months have been perhaps the most difficult our community has ever faced.
A staycation is better than no vacation!
With coronavirus having such a big impact on everyone’s summer plans, we spoke to Jo who has been shielding since March. Like many, Jo has found shielding to be difficult at times, but that hasn’t stopped her from making some incredible memories over the past few months. In this blog she describes her experiences and how you too can still have a summer that you’ll never forget.
How could a coronavirus vaccine help people with blood cancer?
How much hope should people with blood cancer pin on a coronavirus vaccine?
What can we learn from the Cancer Patient Experience Survey data?
We explain the results of the 2019 Cancer Patient Experience Survey data and the likely impact COVID-19 will have on blood cancer care.
We're calling on the government to #SaveOurShielders
We're urging the Government to give financial support to people with blood cancer who can't work from home and whose workplace cannot be made Covid-safe.
Does a chemical found in weedkiller cause lymphoma?
For a number of years there has been concern about a potential link between glyphosate (the active ingredient in many weed killers, including RoundUp) and cancer.
EHA annual conference 2020: the promising future of blood cancer research
Here’s a research round-up of all the exciting breakthroughs in blood cancer research discussed at this year’s European Haematology Association conference. From potential new treatments for people with myeloma to understanding more about how blood cancers develop and why they return.
Our view on the proposed ‘pause’ in shielding
What have the UK Governments announced and what are we doing about it?
What effect is COVID-19 having on blood cancer research?
One of the questions I’ve been asked most often since the UK entered lockdown is “what does COVID-19 mean for blood cancer research?”. After two months of lockdown, what have we learned? What does the future hold and what part will Blood Cancer UK play?
New research hope for those with a rare type of leukaemia
Our research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
Should children with blood cancer go back to school?
As schools begin to re-open following the coronavirus lockdown, we take a closer look at the issues around children with blood cancer returning to classrooms.
